Jan Malm

Jan Malm

Auto-generated profile, based on publicly available information

Jan Malm

Department of Clinical Sciences, Neurosciences, Umeå University, Umea, Sweden

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2015 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
LZLaleh Zarrinkoob
Laleh Zarrinkoob
KAKhalid Ambarki
Khalid Ambarki
AWAnders Wåhlin
Anders Wåhlin
RBRichard Birgander
Richard Birgander
AEAnders Eklund
Anders Eklund
JMJan Malm
Jan Malm
High-resolution phase—contrast magnetic resonance imaging can now assess flow in proximal and distal cerebral arteries. The aim of this study was to describe how total cerebral blood flow (tCBF) is distributed into the vascular tree with regard to age, sex and anatomic variations. Forty-nine healthy young (mean 25 years) and 45 elderly (mean 71 years) individuals were included. Blood flow rate (BFR) in 21 intra- and extracerebral arteries was measured. Total cerebral blood flow was defined as BFR in the internal carotid plus vertebral arteries and mean cerebral perfusion as tCBF/brain volume. Carotid/vertebral distribution was 72%/28% and was not related to age, sex, or brain volume. Total cerebral blood flow (717±123 mL/min) was distributed to each side as follows: middle cerebral artery (MCA), 21%; distal MCA, 6%; anterior cerebral artery (ACA), 12%, distal ACA, 4%; ophthalmic artery, 2%; posterior cerebral artery (PCA), 8%; and 20% to basilar artery. Deviating distributions were observed in subjects with ‘fetal’ PCA. Blood flow rate in cerebral arteries decreased with increasing age ( P<0.05) but not in extracerebral arteries. Mean cerebral perfusion was higher in women (women: 61±8; men: 55±6 mL/min/100 mL, P<0.001). The study describes a new method to outline the flow profile of the cerebral vascular tree, including reference values, and should be used for grading the collateral flow system.

1 September 1997 in Stroke
Verified
Journal Article
Closed access
BKBo Kristensen
Bo Kristensen
JMJan Malm
Jan Malm
BCBo Carlberg
Bo Carlberg
BSBirgitta Stegmayr
Birgitta Stegmayr
CBChrister Backman
Christer Backman
TOTommy Olsson
Tommy Olsson
Background and Purpose The aim of this study was to conduct a population-based epidemiological survey among young adults aged 18 to 44 years in Northern Sweden and furthermore to gain further insight into the etiology of ischemic stroke in this age group. Methods Two studies were done. In the first part, epidemiological data were collected to calculate incidence and mortality from 1991 through 1994. This was based on the World Health Organization Northern Sweden MONICA register of acute stroke events. Eighty-eight first-ever ischemic stroke patients were identified during that period. In the second part, 107 consecutive patients aged 18 to 44 years with ischemic stroke referred to a university hospital were studied prospectively during a 5-year period and were extensively evaluated according to a standardized protocol. On the basis of modified Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria, the patients were classified into eight subtypes of ischemic stroke. Results The average population-based annual incidence rate for ischemic stroke (cases per 100 000 per year) was 11.3 (95% confidence interval, 6.7 to 16.1). The case-fatality rate was 5.7%. According to the modified TOAST criteria, a probable cause of ischemic stroke was identified in 36% and remained unexplained in 21% of cases. Spontaneous cervical arterial dissection was the leading probable etiology (13%). Patent foramen ovale or atrial septal aneurysm was a possible cause of stroke in 28% of cases. The percentages of ischemic stroke attributed to IgG anticardiolipin antibodies (4.7%), atherothrombotic vasculopathy (3.7%), oral contraceptive use (7%), and migraine (1%) were lower than reported in recent clinical series. Conclusions The incidence rate for ischemic stroke was higher than previously reported from most countries in Western Europe. The higher incidence was not explained by a higher prevalence of premature atherosclerotic vasculopathy. Without the additional diagnostic information derived from advanced cardiac imaging, the proportion of indeterminate cases would have constituted 37% of the patients.

1 April 2016 in Continuum
Verified
Journal Article
Closed access
MWMichael A. Williams
Michael A. Williams
JMJan Malm
Jan Malm
Purpose of Review: This article provides neurologists with a pragmatic approach to the diagnosis and treatment of idiopathic normal pressure hydrocephalus (iNPH), including an overview of: (1) key symptoms and examination and radiologic findings; (2) use of appropriate tests to determine the patient’s likelihood of shunt responsiveness; (3) appropriate referral to tertiary centers with expertise in complex iNPH; and (4) the contribution of neurologists to the care of patients with iNPH following shunt surgery. Recent Findings: The prevalence of iNPH is higher than previously estimated; however, only a fraction of persons with the disorder receive shunt surgery. iNPH should be considered as a diagnosis for patients with unexplained symmetric gait disturbance, a frontal-subcortical pattern of cognitive impairment, and urinary urge incontinence, whose MRI scans show enlarged ventricles and whose comorbidities are not sufficient to explain their symptoms. Physiologically based tests, such as the tap test (large-volume lumbar puncture) or temporary spinal catheter insertion for external lumbar drainage with gait testing before and after CSF removal, or CSF infusion testing for measurement of CSF outflow resistance, can reliably identify patients who are likely to respond to shunt surgery. Properly selected patients have an 80% to 90% chance of responding to shunt surgery, and all symptoms can improve following shunt surgery. Longitudinal care involves investigating the differential diagnosis of any symptoms that either fail to respond to shunt surgery or that worsen after initial improvement from shunt surgery. Summary: Neurologists play an important role in the identification of patients who should be evaluated for possible iNPH. With contemporary diagnostic tests and treatment with programmable shunts, the benefit-to-risk ratio of shunt surgery is highly favorable. For more complex patients, tertiary centers with expertise in complex iNPH are available throughout the world.

1 January 2013 in Fluids and Barriers of the CNS
Verified
Journal Article
Open access
PDF file
JMJan Malm
Jan Malm
NGNeill R Graff-Radford
Neill R Graff-Radford
MIMasatsune Ishikawa
Masatsune Ishikawa
BKBo Kristensen
Bo Kristensen
VLVille Leinonen
Ville Leinonen
NRNorman R Relkin
Norman R Relkin
Idiopathic normal pressure hydrocephalus (INPH) is a syndrome of ventriculomegaly, gait impairment, cognitive decline and incontinence that occurs in an elderly population prone to many types of comorbidities. Identification of the comorbidities is thus an important part of the clinical management of INPH patients. In 2011, a task force was appointed by the International Society for Hydrocephalus and Cerebrospinal Fluid Disorders (ISHCSF) with the objective to compile an evidence-based expert analysis of what we know and what we need to know regarding comorbidities in INPH. This article is the final report of the task force. The expert panel conducted a comprehensive review of the literature. After weighing the evidence, the various proposals were discussed and the final document was approved by all the task force members and represents a consensus of expert opinions. Recommendations regarding the following topics are given: I. Musculoskeletal conditions; II. Urinary problems; III. Vascular disease including risk factors, Binswanger disease, and white matter hyperintensities; IV. Mild cognitive impairment and Alzheimer disease including biopsies; V. Other dementias (frontotemporal dementia, Lewy body, Parkinson); VI. Psychiatric and behavioral disorders; VII. Brain imaging; VIII. How to investigate and quantify. The task force concluded that comorbidity can be an important predictor of prognosis and post-operative outcome in INPH. Reported differences in outcomes among various INPH cohorts may be partly explained by variation in the rate and types of comorbidities at different hydrocephalus centers. Identification of comorbidities should thus be a central part of the clinical management of INPH where a detailed history, physical examination, and targeted investigations are the basis for diagnosis and grading. Future INPH research should focus on the contribution of comorbidity to overall morbidity, mortality and long-term outcomes.

2 August 2010 in Annals of Neurology
Verified
Journal Article
Closed access
PSPeter Sundström
Peter Sundström
AWAnders Wåhlin
Anders Wåhlin
KAKhalid Ambarki
Khalid Ambarki
RBRichard Birgander
Richard Birgander
AEAnders Eklund
Anders Eklund
JMJan Malm
Jan Malm

9 January 2007 in Neurology
Verified
Journal Article
Closed access
PDF file
NLN. Lenfeldt
N. Lenfeldt
LKLars-Owe Daniel Koskinen
Lars-Owe Daniel Koskinen
ABA. T. Bergenheim
A. T. Bergenheim
JMJ. Malm
J. Malm
AEA. Eklund
A. Eklund
The accuracy of estimating intracranial pressure in brain tissue (ICPBT) via lumbar space was investigated using preset pressure levels in the interval 0 to 600 mm H2O in patients with communicating hydrocephalus. Lumbar space ICP correlated excellently to ICPBT, demonstrated by a measured mean difference of 10 mm H2O (0.75 mm Hg) and a regression coefficient of 0.98. The concurrence supports the lumbar puncture as an accurate technique to determine ICP in patients with communicating CSF systems.